Labcorp Holdings Inc. Files SEC Form 8-K12B, Notification That A Class of Securities of Successor Issuer Is Deemed To Be Registered Pursuant To Section 12(B): (May 17, 2024).

Předmět:
Zdroj: Health & Medicine Week; 6/7/2024, p10483-10483, 1p
Abstrakt: Labcorp Holdings Inc., a medical laboratory company, has filed a Form 8-K12B with the U.S. Securities and Exchange Commission (SEC). The filing indicates that a class of securities of a successor issuer is now registered under Section 12(b). The company's contact information is provided as 358 S MAIN ST, BURLINGTON NC 27215, 3362291127. This SEC filing is a formal document or financial statement submitted by publicly-traded companies. For more information, the SEC filing can be accessed at https://www.sec.gov/Archives/edgar/data/920148/0000920148-24-000063-index.html. [Extracted from the article]
Databáze: Complementary Index